Existing literature provided a limited understanding of the significance of TREM2 in cancer that is primarily based on the correlation of TREM2 expression with clinical parameters such as the patient survival.4 Accumulating evidence suggested that elevated TREM2 expression correlated with tumor progression and poor patient survival in gastric cancer, glioma, and hepatocellular carcinoma. This evidence concerns the gene TREM2 and gastric cancer.